Conformational Transitions in CD4 Due to Complexation with HIV Envelope Glycoprotein gp120

Journal of Immunology

Volumn 158, Issue 3, 1997, Pages 1157-1164

  Denisova, Galina ^a   Raviv, Daphna ^a   Mondor, Isabelle ^b   Sattentau, Quentin J ^b   Gershoni, Jonathan M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BINDING COMPETITION; CD4+ T LYMPHOCYTE; CHEMISTRY; EPITOPE MAPPING; GENE DELETION; HUMAN; IMMUNOLOGY; MACROMOLECULE; MOUSE; PROTEIN BINDING; PROTEIN CONFORMATION; SOLUBILITY; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; BINDING, COMPETITIVE; CD4-POSITIVE T-LYMPHOCYTES; EPITOPE MAPPING; HIV ENVELOPE PROTEIN GP120; HUMANS; MACROMOLECULAR SUBSTANCES; MICE; MICE, INBRED BALB C; PROTEIN BINDING; PROTEIN CONFORMATION; SEQUENCE DELETION; SOLUBILITY;

EID: 0031065252     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Williams, A. F., and A. N. Barclay. 1988. The immunoglobulin superfamily-domains for cell surface recognition. Annu. Rev. Immunol. 6:381.
2. Kuma, K., N. Iwabe, and T. Miyata. 1991. The immunoglobulin family. Curr. Opin. Struct. Biol. 1:384.
3. Hunkapillar, T., and L. E. Hood. 1989. Diversity of the immunoglobulin gene superfamily. Adv. Immunol. 44:1.
4. Wang, J., Y. Yan, T. P. Garrett, J. Liu, D. W. Rodgers, R. L. Garlick, G. E. Tarr, Y. Husain, E. L. Reinherz, and S. C. Harrison. 1990. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348:411.
5. Ryu, S. E., P. D. Kwong, A. Truneh, T. G. Porter, J. Arthos, M. Rosenberg, X. Dai, N. Xuong, R. Axel, R. W. Sweet, and W. A. Hendrickson. 1990. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 348: 418.
6. Sweet, R. W., A. Truneh, and W. A. Hendrickson. 1991. CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological agent. Curr. Opin Biotechnol. 2:622.
7. Doyle, C., and J. L. Strominger. 1987. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330:256.
8. Gay, D., P. Maddon, R. Sekaly, M. A. Talle, M. Godfrey, E. Long, G. Goldstein, L. Chess, R. Axel, J. Kappler, and P. Marrack. 1987. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature 328:626.
9. Clayton, L. K., M. Sieh, D. A. Pious, and E. L. Reinherz. 1989. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature 339:548.
10. Klatzmann, D., E. Champagne, S. Chamaret, J. Gruest, D. Guetard, T. Hercend, J. C. Gluckman, and L. Montagnier. 1984. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312:767.
11. Dalgleish, A. G., P. C. Beverley, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763.
12. Celada, F., C. Cambiaggi, J. Maccari, S. Burastero, T. Gregory, E. Patzer, J. Porter, C. McDanal, and T. Matthews. 1990. Antibody raised against soluble CD4-gp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibition CD4-gp120 binding. J. Exp. Med. 172:1143.
13. Healey, D., L. Dianda, J. P. Moore, J. S. McDougal, M. J Moore, P. Estess, D. Buck, P. D. Kwong, P. C. Beverley, and Q. J. Sattentau. 1990. HIV infection and fusion of CD4+ cells is separable from virus binding by CD4 monoclonal antibodies. J. Exp. Med. 172:1233.
14. Truneh, A. H., D. Buck, D. R. Cassatt, R. Juszczak, S. Kassis, S. E. Ryu, D. Healey, R. W Sweet, and Q. J. Sattentau. 1991. A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J. Biol. Chem. 266:5942.
15. Burkly, L. C., D. Olson, R. Shapiro, G. Winkler, J. J. Rosa, D. W. Thomas, C. Williams, and P. Chisholm. 1992. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. J. Immunol. 149:1779.
16. Hasunuma, T., H. Tsubota, M. Watanabe, Z. W. Chen, C. I. Lord, L. C. Burkly, J. F. Daley, and N. L. Letvin. 1992. Regions of the CD4 molecule not involved in virus binding or syncytia formation are required for HIV-1 infection of lymphocytes. J. Immunol. 148:1841.
17. Allan, J. S. 1991. Receptor-mediated activation of immunodeficiency viruses in viral fusion. Science 252:1322.
18. Moore, J. P., J. A. McKeating, R. A. Weiss, P. R. Clapham, and Q. J. Sattentau. 1991. Receptor-mediated activation of immunodeficiency viruses in viral fusion-response. Science 252:1322.
19. Sattentau, Q. J., and J. P. Moore. 1991. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:407.
20. Sattentau, Q. J., J. P. Moore, F. Vigraux, F. Traincard, and P. Poignard. 1993. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67:7383.
21. Gershoni, J. M., G. Denisova, D. Raviv, N. I. Smorodinsky, and D. Buyaner. 1993. HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex. FASEB J. 7:1185.
22. Markus, T., J. P. Moore, C. Furman, M. Charles, D. D. Ho, J. Robinson, and J. Sodroski. 1993. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:3978.
23. Devico, A. L., R. Rahman, J. Welch, R. Crowley, P. Lusso, M. G. Sarngadharan, and R. Pal. 1995. Monoclonal antibodies raised against covalently cross-linked complex of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp120. Virology 211:583.
24. + cells from virus binding. J. Exp. Med. 172:1273.
25. + cells. J. Virol. 66:4784.
26. Lazaro, I., D. Naniche, N. Signoret, A-M. Bernard, D. Marguet, D. Klatzmann, T. Dragic, M. Alizon, and Q. J. Sattentau,. 1994. Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26. J. Virol. 68:6535.
27. Harlow, E., and D. Lane. 1988. Storing and purifying antibodies. In Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, p. 298.
28. Gershoni, J. M. 1988. Protein blotting: a manual. In Methods of Biochemical Analysis. Vol. 33. D. Glick, ed. Wiley-Interscience, pp. 1-58.
29. Gershoni, J. M., F. E. Davis, and G. E. Palade. 1985. Protein blotting in uniform or gradient electric fields. Anal. Biochem. 144:32.
30. Clavel, F., and P. Chameau. 1994. Fusion from without directed by human immunodeficiency virus particles. J. Virol. 68:1179.
31. Fisher, A. G., E. Collati, L. Ratner, R. C. Gallo, and F. Wong-Staal. 1985. A molecular clone of HTLV-III with biological activity. Nature 316:262.
32. Corbeau, P., M. Benkirane, R. Weil, C. David, S. Emiliani, D. Olive, C. Mawas, A. Serre, and C. Devaux. 1993. Ig CDR3-like region of the CD4 molecule involved in HIV-induced syncytia formation but not in viral entry. J. Immunol. 150:290.
33. Stura, E. A., R. L. Stanfield, G. G. Fieser, S. Silver, M. Roguska, L. M. Hincapie, H. K. B. Simmerman, A. T. Profy, and I. A. Wilson. 1992. Crystallization, sequence, and preliminary crystallographic data for an antipeptide Fab 50.1 and peptide complexes with the principal neutralizing determinant of HIV-1 gp120. Proteins Struct. Funct. Genet. 14:499.
34. Stanfield, R. L., M. Takimoto-Kamimura, J. M. Rini, A. T. Profy, and I. A. Wilson. 1993. Major antigen-induced domain rearrangement in an antibody. Structure 1:83.
35. Bhat, T. N., G. A. Benttley, T. O. Fishman, G. Boulot, and R. J. Poljak. 1990. Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding. Nature 347:483.
36. Feng, Y., C. C. Broder, P. E. Kennedy, E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872.